Abcam’s multiplex immunoassays combine unique Firefly? hydrogel technology with Abcam’s high-performance antibodies to simultaneously measure up to 75 different proteins in a mere 12.5 μL of sample. With sensitivity below 1 pg/mL, the assay can provide rapid multiplex data within hours1, even in complex matrices with low target concentrations.
Unlike many other multiplex assays which are bead-based, these assays can be run on any of the most common flow cytometers, deliver 4–5 logs of linear dynamic range, and include free, easy-to-use analysis software. Additionally, researchers can choose from a rapidly growing menu of analytes to create a customized, ready-to-use panel to analyze complex inflammatory responses to diseases or treatments.
Due to shared antibody pairs, users can seamlessly switch between Abcam’s 90 minute SimpleStep ELISA? assays and multiplex immunoassays, while maintaining high correlation. For even more flexibility, Abcam offers its multiplex immunoassays as both a convenient service and as kits for researchers to employ in their own labs.
To find out more, visit https://http://www.jiaozao.icu/multipleximmunoassay1. Firefly? multiplex immunoassays have been demonstrated to assess 41 analytes per well in 3.5 hours (internal data).